AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2005
Mar 9, 2005
30339_dirs_2005-03-09_773610e6-bf87-4d9c-ba68-a494d7e586a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-03-07
Reporting Person: ELLERS STEVEN A (Pres., Pharma. Systems Div.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-03-07 | Common Stock | A | 10577 | — | Acquired | 83718.2812 | Direct |
| 2005-03-07 | Common Stock | M | 18920 | $13.3750 | Acquired | 102638.2812 | Direct |
| 2005-03-07 | Common Stock | F | 9912 | $25.5300 | Disposed | 92726.2812 | Direct |
| 2005-03-07 | Common Stock | F | 2757 | $25.5300 | Disposed | 89969.2812 | Direct |
| 2005-03-07 | Common Stock | A | 4771.91 | $25.5700 | Acquired | 16066.9019 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-03-07 | Stock Option (Right to Buy) | $13.3750 | M | 18920 | Disposed | 2006-05-01 | Common Stock (18920.00) | Direct |
| 2005-03-07 | Stock Option (Right to Buy) | $25.5300 | A | 40000 | Acquired | 2015-03-09 | Common Stock (40000.00) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2770.8023 | Indirect |
Footnotes
F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
F2: Bonus and incentive shares granted on 3/7/05.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12